BCR-ABL-IN-7

BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor. BCR-ABL-IN-7 effectively inhibits activities of WT and T315I mutant ABL kinases. BCR-ABL-IN-7 can be used for the research of chronic myeloid leukemia (CML) research.

Product Specifications

CAS Number

688050-42-2

Field of Research

Cell Biology

Purity

>98% (HPLC)

Smiles

C (N) (=O) C=1C2=C (SC1NC (=O) C=3C=C (ON3) C4=CC=C (F) C=C4) CCCC2

Molecular Formula

C19H16FN3O3S

Molecular Weight

385.41

Storage Conditions

Storage temperature: -20°C. Stability: ≥ 2 years

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

orb1100972-01 48 Tests

Human 10-HETE (10-Hydroxyeicosatetraenoic Acid) ELISA Kit

View Details

orb1100972-02 96 Tests

Human 10-HETE (10-Hydroxyeicosatetraenoic Acid) ELISA Kit

View Details

K7339407 1.0 µg DNA

Grap2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

View Details

orb1684661 5 mg

Decarine

View Details

sc-431031-ACT-2 20 µg

H2-Q6 CRISPR Activation Plasmid (m2)

View Details

PV305577 500 ng

SLC25A15 Protein Vector (Rat) (pPM-C-His)

View Details